RECCE® 435 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

22,674 results for “RECCE® 435”

Trials

View all 18439 →

Efficacy and Safety Study of MP-435 in Combination With Methotrexate (MTX) in Patients With Rheumatoid Arthritis

112 participants · First posted Jun 14, 2010

Comprehensive Characterization of Immune Response Induced by Adjuvanted Glycoprotein E (gE)-Based Recombinant VAccine Zoster in Vulnerable Population Receiving ImmunOmodulaNt Therapies

150 participants · First posted Apr 16, 2026

Active, not recruiting

Immune Response of Shingrix Vaccine in People Living With HIV (> 50 y.o.) Compared to Age-matched Controls

225 participants · First posted Oct 12, 2022

Drugs

View all 1429 →

RECCE-435

RECCE 529

SYC-435

Organizations

View all 11 →

RECCE PHARMACEUTICALS LTD

Australia

GENOMIC HEALTH, INC.

United States

Pelican Therapeutics, Inc.

United States

News

View all 2795 →

Recce Pharmaceuticals' Phase II Trial of R327G for ABSSSI Reaches Halfway Enrollment

Recce Pharmaceuticals Initiates Phase 3 Trial for Novel Diabetic Foot Infection Treatment in Indonesia

Recce Pharmaceuticals Secures A$15.8 Million to Advance Phase III Trials for Novel Anti-Infectives

Page 1 of 2268